Concentrated Bicarbonate Haemodialysis Solution AC-F 1130G-Part A (article 2814)

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Calcium chloride dihydrate 6.7 g/L; Glacial acetic acid 6.3 g/L; Glucose monohydrate 69.4 g/L; Magnesium chloride hexahydrate 1.4 g/L; Potassium chloride 2.6 g/L; Sodium chloride 214.8 g/L

Commercializzato da:

Fresenius Medical Care Australia Pty Ltd (NZ)

INN (Nome Internazionale):

Calcium chloride dihydrate 6.7 g/L

Forma farmaceutica:

Dialysis solution

Composizione:

Active: Calcium chloride dihydrate 6.7 g/L Glacial acetic acid 6.3 g/L Glucose monohydrate 69.4 g/L Magnesium chloride hexahydrate 1.4 g/L Potassium chloride 2.6 g/L Sodium chloride 214.8 g/L Excipient: Purified water Sodium hypochlorite

Confezione:

Bottle, plastic, 5L bottle, 5 L

Classe:

General sale

Tipo di ricetta:

General sale

Prodotto da:

Fresenius Medical Care Australia Pty Ltd

Dettagli prodotto:

Package - Contents - Shelf Life: Bottle, plastic, 5L bottle - 5 L - 24 months from date of manufacture stored at or below 30°C - Bottle, plastic, 10L bottle - 10 L - 24 months from date of manufacture stored at or below 30°C

Data dell'autorizzazione:

1994-05-27